Newborn screening (NBS) is one of the most impactful public health programs in the United States, especially for the neuromuscular diseases spinal muscular atrophy (SMA) and Pompe disease. Through newborn screening, infants born with these diseases can benefit from therapies early in life, improving their health outcomes.
Author